HomeCompareORXOY vs PLD

ORXOY vs PLD: Dividend Comparison 2026

ORXOY yields 71.43% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $4.78M in total portfolio value· pulled ahead in Year 9
10 years
ORXOY
ORXOY
● Live price
71.43%
Share price
$2.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.12M
Annual income
$299,297.66
Full ORXOY calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — ORXOY vs PLD

📍 PLD pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORXOYPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORXOY + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ORXOY pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORXOY
Annual income on $10K today (after 15% tax)
$6,071.43/yr
After 10yr DRIP, annual income (after tax)
$254,403.01/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,783,713.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORXOY + PLD for your $10,000?

ORXOY: 50%PLD: 50%
100% PLD50/50100% ORXOY
Portfolio after 10yr
$3.52M
Annual income
$2,525,011.42/yr
Blended yield
71.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ORXOY
No analyst data
Altman Z
-0.1
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORXOY buys
0
PLD buys
0
No recent congressional trades found for ORXOY or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORXOYPLD
Forward yield71.43%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$1.12M$5.91M
Annual income after 10y$299,297.66$4,750,725.19
Total dividends collected$960.2K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ORXOY vs PLD ($10,000, DRIP)

YearORXOY PortfolioORXOY Income/yrPLD PortfolioPLD Income/yrGap
1$17,843$7,142.86$11,241$540.96+$6.6KORXOY
2$31,003$11,911.12$13,019$991.13+$18.0KORXOY
3$52,515$19,342.29$15,801$1,870.97+$36.7KORXOY
4$86,812$30,620.19$20,609$3,701.21+$66.2KORXOY
5$140,194$47,305.90$29,919$7,867.97+$110.3KORXOY
6$221,406$71,397.66$50,631$18,617.74+$170.8KORXOY
7$342,284$105,380.00$105,528$51,352.20+$236.8KORXOY
8$518,499$152,255.26$287,364$174,449.42+$231.1KORXOY
9← crossover$770,345$215,550.93$1,081,760$774,280.77$311.4KPLD
10$1,123,567$299,297.66$5,908,209$4,750,725.19$4.78MPLD

ORXOY vs PLD: Complete Analysis 2026

ORXOYStock

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.

Full ORXOY Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ORXOY vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORXOY vs SCHDORXOY vs JEPIORXOY vs OORXOY vs KOORXOY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.